A Determination of the Relative Risk of Hepatotoxicity Among Anti-Epileptic Drugs in the FDA Adverse Event Reporting System

Time

Wed, Jun 17 9:00AM
W 16

Title

A Determination of the Relative Risk of Hepatotoxicity Among Anti-Epileptic Drugs in the FDA Adverse Event Reporting System

Abstract Summary

ORAL PRESENTATION SCHEDULED: Wednesday, June 17 in Session #2B at 11:49 - 11:54 am in the Exhibit Hall Poster Area (Hall A entrance)

The risk of hepatotoxicity was compared in patients with SE treated with AEDs using the proportional reporting ratio (PRR) for events submitted to FAERS between 2011Q2-2014Q1.


Poster Presenter

Roshawn Watson
PharmD, PhD, RPh,
Associate Director of Medical Writing,
ON Clinical Consulting
United States